Background: Individual studies have demonstrated the potential of diffusion-weighted magnetic resonance imaging (DWI-MRI) for identifying inflamed bowel segments. However, these studies were conducted with rather small patient cohorts and in most cases by means of MR enterography only. Purpose: To demonstrate the feasibility of detecting inflamed bowel segments in a large collective of patients with Crohn's disease using DWI in MR enteroclysis and MR enterography and to compare the results of both techniques, also considering clinical parameters by means of the Harvey-Bradshaw Index (HBI). Material and Methods: Ninety-six patients underwent MRI enteroclysis and 35 patients MR enterography, both with additional DWI. The HBI as well as apparent diffusion coefficients (ADC) in areas of inflamed and normal bowel wall were determined. Thus resulting in 208 bowel segments that were visualized and subsequently statistically analyzed. Results: There were no significant differences in ADC values in MR enteroclysis and MR enterography (P ¼ 0.383 in inflammation, P ¼ 0.223 in normal wall). Areas of inflammation showed statistically highly significant lower ADC values than areas of normal bowel wall (P < 0.001). An ADC threshold of 1.56 Â 10 -3 mm 2 /s can distinguish between normal and inflamed bowel segments with a sensitivity of 97.4% and a specificity of 99.2%. A highly significant correlation could be shown between ADC and HBI values (P ¼ 0.001). Conclusion: DWI-MRI facilitates recognition of inflamed bowel segments in patients with Crohn's disease and the ADC values show an excellent correlation to the HBI. There were no significant differences in ADC values in MR enteroclysis and MR enterography. An ADC threshold of 1.56 Â 10 -3 mm 2 /s differentiates between normal and inflamed bowel wall.
Introduction
Crohn's disease represents one of the most frequent chronic inflammatory bowel diseases (IBD) in western nations with a rising incidence of 3.1-14.6 per 100,000 and a prevalence of per 100,000 (1) . Therapeutic management of Crohn's disease is multimodal, but primarily led by patients' clinical presentation. Treatment is initially conservative, but complications such as fistulae or abscesses are indications for surgery. Understanding the morphological basis of the patient's symptoms and estimating inflammatory activity is of crucial importance for decision-making and differentiation from other acute or chronic intestinal disorders (2) . Clinicians usually use various indices, such as the Crohn's Disease-Activity Index (CDAI) (3), the Severity-Activity Index (SAI) (4) , or the Harvey-Bradshaw Index (HBI) (5) , which have the disadvantage of being time-consuming and dependent on patients' subjective assessments.
Individual studies have demonstrated the potential of diffusion-weighted magnetic resonance imaging (DWI-MRI) for identifying inflamed bowel segments (6, 7) as well as for predicting therapeutic efficacy (8) . However, these studies were conducted with rather small patient cohorts and in most cases by means of MR enterography only.
Object of this study was to confirm the utility of DWI-MRI to quantify the inflammation activity in a large patient collective in MR enteroclysis and MR enterography and to compare the results of both techniques, also considering clinical parameters by means of the HBI.
Material and Methods
Data for our retrospective study was collected out of routine examinations between 2009 and 2014, all patients in this period were included in the study. Up to October 2012, we performed MR enteroclysis, followed by MR enterography since November 2012. DWI-MRI was obtained in addition to conventional MRI sequences in a total of 137 patients, which initially were included in the study.
Prior to examination, patients were assessed for the standard contraindications for MRI including metal implants, pacemakers, claustrophobia, and advanced renal insufficiency (GFR < 30 mL/min), as well as allergy or hypersensitivity to gadolinium.
For MR enteroclysis, small bowel distension was accomplished by instillation of a 1% tylose solution through a duodenal catheter, placed under fluoroscopic monitoring at the ligament of Treitz. Instillation of the tylose solution was continued during the MR examination using a pump with a total volume of 1500 mL. Progress of bowel distension was monitored with heavily T2-weighted sequences (T2 RARE), while the actual examination sequences were initiated as soon as distension had reached the cecum.
For MR enterography, patients ingested 7.5 mg of locust bean gum (Nestargel Õ , Nestle Nutrition GmbH, Munich, Germany) and 37.5 mg of mannitol dissolved in 1500 mL of water. This was gradually applied over 90 min before MRI examination.
In order to minimize motion artifacts secondary to bowel peristalsis, patients received 10 mg of N-butylscopolamine (Buscopan Õ , Boehringer, Ingelheim, Germany) intravenously at the beginning and again approximately half-way of the examination. The medication was not administered in patients with known contraindications, such as glaucoma, cardiac arrhythmia, or prostatic hyperplasia.
All examinations were performed in supine position using a 1.5 Tesla MRI (Siemens Avanto Õ , Erlangen, Germany). Imaging began from the diaphragm and continued caudally to the anocutaneous line. Details of the examination protocol are given in Table 1 . In all patients, Gadobutrol (Gadovist Õ , Bayer Vital, Leverkusen, Germany) was used as contrast media at a dose of 0.1 mL/kg of body weight.
Imaging datasets were blinded concerning the clinical symptomatology and interpreted in consensus by two experienced radiologists. An image quality score was achieved in all patients using a scale of 1 to 5 (very good, good, moderate, poor, impossible), based on bowel distension and limiting artifacts. In a first step, active inflammatory bowel loops were detected using the morphological sequences (T1W before and after Gadolinium, T2W), the main criterion was a minimum wall thickening of 4 mm with ambient mesenteric fatty infiltration. Regional lymphadenopathy was additionally described, but was not a necessary precondition. In a second step, quantitative apparent diffusion coefficient (ADC) values were established based on regions of interest (ROI) with an area of 1 mm 2 each.
In patients without inflammatory findings, three ROIs were placed in the normal bowel wall and the mean ADC value was recorded for further statistical evaluation. In patients with active inflammation, a total of six ROIs were placed, three in the inflamed wall and three in the normal wall. Corresponding mean ADC values in both the inflamed and normal bowel wall segments were recorded. If active inflammatory changes were detected in more than one section of the intestine, the bowel loop with the thicker wall or with more pronounced creeping fat was selected. Changes of the colonic wall were disregarded, since usually there was no sufficient distension and this was not aim of our study.
In six patients an inflammatory bowel segment was found, but no Crohn's disease was known or histologically proven. Out of these, two patients had an infectious inflammation, in one patient an ulcerative colitis with backwash-ileitis was diagnosed, one patient suffered from an invagination, and two cases remained unclear. These six patients were excluded from the study. Finally, a total of 131 patients and 208 bowel wall segments were included in our statistics.
Additionally, we tried to determine the HBI of all patients retrospectively. The evaluation was based on electronically stored documents nearby the date of MR examination. We succeeded in 87 patients (66.4%); in the others calculation was impossible due to lack of appropriate information.
Statistical analysis was performed using SPSS Õ Statistics software V22.0 (IBM Corp., Armonk, NY, USA). Normal distribution was tested using the Kolmogorov-Smirnov test. Correlations were tested using Pearson's product-moment-correlation or Spearman's rank correlation, as appropriate. Comparisons of different groups were performed using the Mann-Whitney U-test. In all calculations, P values < 0.05 were considered statistically significant and P values < 0.01 were considered highly significant. Threshold value calculations were performed using receiver operating characteristic (ROC) curves.
Results
By comparison of MR enteroclysis (96 cases) and MR enterography (35 cases), none of the recorded values showed a significant difference (Table 2) , so below we only describe analysis with one pooled group. Summarizing all patients, we had a mean image quality score of 2.30 AE 0.76 (range, 1-4).
Patient collective
A total of 131 patients (70 girls/women, 61 boys/men; age range, 12-81 years; mean age, 39.3 AE 16.6 years) were included in the study. In 89 patients (67.9%), Crohn's disease was histologically confirmed at time of examination or within 4 weeks afterwards. These patients had been referred to MRI either for work-up of new or progressive symptoms, for monitoring therapeutic response, or under the suspicion of a chronic IBD. Consecutively, we had a control group of 42 patients (32.1%). The main indication for MRI examination in these patients was the initial suspicion of a 
Qualitative analysis
In the morphological MR sequences bowel wall changes consistent with an active inflammatory process were described in 77 of 89 patients with proven Crohn's disease (86.5%). In all these patients, DWI sequences showed restricted diffusion in the corresponding areas ( Fig. 1) , prompting an additional quantitative analysis. Twelve patients (13.5%) with proven Crohn's disease showed no active inflammation, some of them chronic changes or fibrosis. In three patients, DWI appeared slightly positive, however, these changes were without any correlate in the morphological sequences and could be attributed to motion artifacts.
Quantitative analysis on the basis of ADC values
The mean ADC value for all 208 analyzed bowel segments was 1.77 Â 10 -3 AE 0.47 Â 10 -3 mm 2 /s (range, 0.80 Â 10 -3 mm 2 /s -2.88 Â 10 -3 mm 2 /s). When analyzed separately, mean ADC values for the groups with and without active inflammation differed greatly with P < 0.001. Thus, the mean ADC value for normal bowel segments was 2.09 Â 10 -3 AE 0.24 Â 10 -3 mm 2 /s, while pathologic areas showed a mean ADC value of 1.23 Â 10 -3 AE 0.20 Â 10 -3 mm 2 /s (Fig. 2) . In 77 patients with active inflammation of the small bowel, the mean difference in ADC values between normal and inflamed bowel wall was 0.88 Â 10 -3 AE 0.24 Â 10 -3 mm 2 /s with an average drop in ADC values of 41.3 AE 9.2%. Details of the comparison between patients with and without known Crohn's disease are listed in Table 3 .
Clinical parameters
The mean HBI of all patients was 4.94 AE 4.27 (range, 0-24). There was a high significant difference between patients with and without Crohn's disease (Table 3) . Also, the correlation of HBI with ADC values (thickened wall in Crohn's patients, normal wall in other patients) showed high significant statistics with P ¼ 0.001.
Threshold value
The ranges of ADC values in the groups with and without active inflammation showed only a slight overlap (0.80-1.76 Â 10 -3 mm 2 /s and 1.54-2.88 Â 10 -3 mm 2 /s for inflamed and normal tissue, respectively). The distributions are shown in Fig. 3 . Using a ROC curve, we calculated a threshold value of 1.56 Â 10 -3 mm 2 /s (Fig. 4) . The area under the curve (AUC) was 0.998 (95% confidence interval, 0.995-1.000). Using this cutoff, it is possible to differentiate between normal and inflammatory wall with a sensitivity of 97.4% and a specificity of 99.2%. A rounded threshold value of 1.6 Â 10 -3 mm 2 /s, more practical for daily routine, exhibited an unchanged sensitivity of 97.4% and a slightly reduced specificity of 98.5%.
Discussion
An individualized therapy of Crohn's disease depends on precise knowledge of the current inflammatory activity. Up to now this has been estimated on the basis of clinical symptoms, biochemical parameters, and standardized activity indices. These indices have the disadvantage of including subjective factors such as patient-reported pain intensity. Additionally, some indices require the observation of symptoms over a considerable period of time. Even though sophisticated endoscopic methods for examining the small bowel have been introduced, radiological imaging remains the method of choice for diagnosing and monitoring inflammatory changes as it permits examination of the entire small bowel. In particular, the terminal ileum, which is most commonly affected in Crohn's disease, cannot be easily examined by conventional ileocolonoscopy in all cases (9) . In addition, cross-sectional imaging can reveal extraluminal pathologies (10) . The usability of DWI in the work-up of complications associated with Crohn's disease has been demonstrated in the visualization of fistula systems (11) . MRI has an established but still expanding role, being an easily obtainable, non-invasive examination with no radiation exposure. Most publications focus on detection of inflamed bowel segments using conventional MRI sequences (12, 13) ; only a few have addressed the value of DWI. DWI-MRI is based on a spatially resolved representation of the diffusion of water molecules (Brownian molecular movement) (14) . Since this does not necessarily require intravenous contrast agents (15) , even patients with contraindications could be examined. Furthermore, the addition of DWI sequences does not significantly prolong the examination; in fact, examination times in the future may even be shortened by waiving contrast-enhanced sequences. ADC values seem to be strongly dependent both on technical as well as biological factors. Thus they cannot be transferred easily to different scanners. Despite various approaches, this problem could not be solved satisfactorily until now.
Since the first publication on the clinical application of DWI in 1986, it is routinely used in neuroradiological diagnostics (16) . In 2009, there were first suggestions to utilize DWI to detect inflammatory bowel changes in a small study with 11 patients (6) . The authors observed significant differences between inflamed and noninflamed bowel segments. The ADC values, however, were higher than those in our study, with a calculated threshold value of 2.0 Â 10 -3 mm 2 /s. Histological examination of inflamed bowel segments reveals extensive infiltration of inflammatory cells, leading to the conclusion that the restricted diffusion of water molecules is presumably due to a significantly increased cell density and viscosity.
In 2011, ADC values of 18 patients with active Crohn's disease were compared with parameters from a dynamic, contrast-enhanced MR enterography (17) , reasoning that differentiation between pathologic and normal bowel segments is possible using DWI. A larger study demonstrated the ability of DWI to detect bowel wall inflammation in the colon (18) . The authors did not perform a quantitative analysis, but introduced their own qualitative and partially subjective interpretation algorithm and waived bowel preparation, which certainly enhances patient compliance, but limits both the diagnostic value and the sensitivity (19) , since it may mask inflammation in non-distended bowel segments (20) . In a study with 31 patients (21), again without specific bowel preparation, average ADC values in inflamed bowel segments were significantly lower than those in normal tissue, however a 1.0 Tesla MR scanner was used. Although no threshold value was calculated, the overall measurements were higher than those observed in our study.
Another study with 31 patients (7) calculated an identical threshold value of 1.6 Â 10 -3 mm 2 /s for differentiating between inflamed and normal bowel wall. The same study group, but with a larger number of patients (22) , showed an ADC threshold of 1.9 Â 10 -3 mm 2 /s, here only MR enterography was performed. In recent publications, authors describe the usefulness of DWI as an additional instrument to detect inflamed bowel segments (23) (24) (25) . However, all three studies were based on data from MR enterography only and ADC thresholds have not been calculated.
In most studies researchers have not used conventional MRI sequences as the standard of comparison. So ADC values were compared with findings of barium fluoroscopy or histological findings in surgical specimens (21, 24) ; other authors use endoscopic findings as gold standard (6, 18) . In our study we selected conventional native and contrast-enhanced MRI sequences acquired during the same examination as the standard of comparison for ADC values, which has the advantage of more exact and reproducible results since comparability of examinations with different acquisition times is diminished due to intestinal peristalsis.
MRI has a very high acceptance in patients, which is only reduced by bowel preparation and the fluoroscopically guided placement of a duodenal catheter. This can, however, be dispensed using MR enterography with oral distension methods, e.g. locust bean gum (26) . Most studies use MR enterography to acquire ADC values. We are not aware of a study comparable to ours investigating DWI in Crohn's disease based on MR enteroclysis and MR enterography, but there seems to be no essential difference in the results of both methods. Initially we were concerned that the probably better bowel distension in MR enteroclysis leads to very thin bowel walls especially in normal segments, which could complicate ROI placement, however, we could set sufficient ROIs in all cases.
Finally, DWI-MRI is suitable not only for highly sensitive detection of inflammatory, but also malignant changes in the bowel (27) (28) (29) . Kilickesmez et al., studying malignant diseases involving the rectum and sigmoid colon, selected a study design comparable to ours (30) and observed significantly lower ADC values in malignant bowel tissue with a threshold value of 1.14 Â 10 -3 mm 2 /s. This cutoff emphasizes that malignant processes have even lower ADC values than inflammatory changes.
Especially in the case of HBI as a clinical index, there seems to be a good correlation with ADC values. Similar results were already shown in the literature (31) , however, with a small cohort of only 20 patients. Rimola et al. developed the magnetic resonance index of activity (MaRIA), which is designed to identify and quantitatively assess inflammatory changes in the ileum and colon secondary to Crohn's disease exclusively on the basis of MRI parameters (32, 33) .
Nonetheless, our study has some limitations. In addition to the retrospective study design we reviewed imaging data acquired exclusively with our 1.5 Tesla MRI unit. Although we have conducted examinations using a 3 Tesla scanner in the meantime, further protocol optimization is required due to significant artifacts. In spite of the small size of our ROIs, distortions secondary to partial volume effects cannot be completely excluded. This affects especially normal bowel segments. We attempted to minimize this potential error by a high number of cases and by performing threefold measurements with subsequent calculation of mean values, which seem to have been successful, given the comparability of our findings with results published by other researchers. Furthermore, our study group consisted of patients where active inflammation or normal bowel walls were predominant; there were only few patients with chronic/fibrotic alterations only. This is due to the fact that clinicians are mostly concerned if there is active inflammation or not and order a MRI examination typically with this question, which influences patient selection. We also discussed the possibility to make a head-to-head comparison of ADC values with matched pairs of patients, but this could not be realized in this retrospective setting due to many differences in drug therapy, disease duration, etc., and is reserved for prospective studies.
In conclusion, MRI is a non-invasive method to detect inflammatory intestinal wall changes. By means of additional DWI, an objective distinction between inflammatory and normal intestine segments is possible and the ADC values show an excellent correlation to clinical parameters represented by the HBI. Thereby in many cases even the intravenous application of contrast agent could be unnecessary. There seems to be no difference in ADC values between MR enteroclysis and MR enterography.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
